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Abstract 
The area postrema mediates the hypophagic effect of the pancreatic hormone amylin and is 
also sensitive to glucagon-like peptide 1 (GLP-1). Protein seems to modulate amylin 
responsiveness because amylin seems to produce a stronger hypophagic effect and a stronger 
c-Fos expression when protein is absent from the diet.  Accordingly, amylin induces a 
stronger c-Fos expression in the AP when injected in fasted compared to ad libitum fed rats. 
Here we tested the hypothesis that diet-derived protein attenuates the amylin dependent 
suppression of feeding and AP activation using isocaloric diets that differed in their protein 
content. Moreover, we investigated whether peripheral amino acid injection attenuates 
amylin-induced c-Fos expression in fasted rats. Since recent evidence suggests that GLP-1 
may also reduce eating via the AP we tested whether 24h fasting also increases neuronal AP 
responsiveness to GLP-1 similar to the fasting-induced increase in amylin responsiveness. 
Finally, we used the calcitonin receptor (CTR) as an immunohistochemical marker for 
amylin-receptive AP neurons to investigate whether amylin’s target neurons differ from GLP-
1 responsive AP neurons. We also dissociated amylin responsive cells from neurons 
implicated in other AP-mediated functions such as aversion or blood pressure regulation. For 
this purpose we conducted c-Fos/CTR double staining after LiCl or angiotensin II treatment, 
respectively. Amylin (5 μg/kg sc) was more effective to reduce the intake of a 1% vs. an 8% 
or 18% protein diet and to induce c-Fos expression in the AP in rats receiving 1% vs. 18% 
protein diet. Increased protein intake was associated with increased blood amino acid levels. 
Peripheral injection of amino acids (1g/kg ip) attenuated the amylin-induced AP activation in 
24h fasted rats. Similar to amylin, GLP-1 (100 μg/kg ip) elicited a significant c-Fos response 
only in fasted but not in ad libitum fed rats. However, in contrast to a high co-localization of 
amylin-induced c-Fos and CTR (68%), no c-Fos/CTR co-localization occurred after treatment 
with GLP-1 or the GLP-1R agonist exendin 4 (2 μg/kg ip). Similarly, LiCl (76mg/kg ip) or 
AngII (50 μg/kg sc) lead to c-Fos expression only in CTR negative AP neurons.  
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In conclusion, our findings support a protein-dependent modulation of behavioral and 
neuronal amylin responsiveness under equicaloric feeding conditions. Amino acids might 
contribute to the inhibitory effect of diet-derived protein to reduce amylin-induced neuronal 
AP activation. Neuronal AP responsiveness to GLP-1 is also increased in the fasted state 
suggesting that diet-derived nutrients may also interfere with AP-mediated GLP-1 effects. 
Nevertheless, the primary target neurons for amylin appear to be distinct from cells targeted 
by GLP-1 and by stimuli producing aversion (LiCl) or contributing to blood pressure 
regulation (AngII) via the AP. Since amylin and GLP-1 analogs are targets for the treatment 
of obesity, the nutrient-dependent modulation of AP responsiveness might entail implications 
for such therapeutic approaches. 
 
Key words: food intake, glucagon-like peptide-1 receptor, exendin, brainstem, area postrema 
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1. Introduction 
The pancreatic hormone amylin acts as a satiation signal via an excitation of area postrema 
(AP) neurons [1, 2]. Peripheral injection of amylin induces a c-Fos expression in 
noradrenergic AP neurons. Similar to a complete AP ablation [3], a specific chemical lesion 
of noradrenergic AP neurons blocks amylin’s hypophagic affect [4]. The functional amylin 
receptor consists of the calcitonin receptor (CTR) as core component co-expressed with 
receptor activity modifying protein 1 or 3 (RAMP1, RAMP3) [5, 6]. The CTR and RAMP3 
are expressed in the AP [7, 8]. We recently demonstrated that amylin induces a stronger c-Fos 
expression in 24h fasted vs. ad libitum fed rats [9]. This effect appeared to depend on diet-
derived protein because the amylin-induced c-Fos expression was attenuated when rats were 
fed a non-caloric diet supplemented with protein while glucose or fat supplementation did not 
affect the amylin response [9].  
In our current work we extended these studies by using isocaloric diets with different protein 
content (1%, 8%, 18%) in order to minimize the possible influence of the diet’s caloric 
density. Differences in protein intake are likely to result in altered levels of circulating amino 
acids, which might exert a direct or indirect signaling function modulating the central amylin 
sensitivity. Due to the lack of a functional blood-brain-barrier in the AP, blood-borne amino 
acids might directly act on AP neurons. In order to assess the possible role of circulating 
amino acids in the modulation of the responsiveness of AP neurons to amylin we investigated 
whether the amylin-induced c-Fos response in the AP of fasted rats is attenuated by 
intraperitoneal administration of amino acids. 
The AP may also represent a target structure for glucagon-like peptide 1 (GLP-1). GLP-1 is 
released by L-cells in response to nutrient stimuli [10, 11]. In addition GLP-1 can also be 
released locally in the AP from GLP-1ergic nerve terminals of enteroceptive neurons located 
in the nucleus of the nucleus of the solitary tract (NTS) [12, 13]. GLP-1 receptor (GLP-1R) 
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mRNA is highly abundant in the AP and peripherally injected radiolabled GLP-1 binds to 
these receptors [12, 14]. Both exogenous GLP-1 and the GLP-1R agonist exendin-4 induce a 
c-Fos response in the AP [15] and both peptides reduce meal size in rats [16]. The AP 
mediates the hypophagic effect of GLP-1 infused into the hepatic portal vein [17]. Due to the 
similarities between amylin and GLP-1 we hypothesized that neuronal GLP-1 responsiveness 
of the AP might also be affected by the feeding status. To test this we compared the GLP-1-
induced c-Fos expression in fasted vs. ad libitum fed rats.     
The AP is not only involved in the physiological control of eating. It also has a crucial 
function as a so-called chemoreceptor trigger zone for the sensing and processing of aversive 
and nausea-inducing stimuli [18]. Unlike amylin [1, 19], GLP-1 plays a role in the induction 
of nausea and conditioned taste aversion [20]. Interestingly, c-Fos expression induced in the 
AP by the aversive stimulus lithium chloride (LiCl) is mediated by GLP-1 [21]. The 
divergence in the aversive responses induced by amylin and GLP-1 suggests the existence of 
discrete subpopulations of AP neurons that are targeted by amylin or GLP-1, respectively. 
Assuming that amylin-responsive AP neurons express the CTR we conducted 
immunohistological CTR/c-Fos double staining studies in order to analyze whether GLP-1 or 
its agonist exendin-4 activate AP neurons that differ from cells that are activated by amylin. 
As a commonly used model for aversion we also included LiCl-treated animals in these 
studies. Furthermore, we used angiotensin II (AngII) as an additional functional stimulus 
because AngII is thought to primarily modulate the autonomic control of blood pressure but 
not feeding behavior via the AP [22]. 
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2. Materials and Methods 
2.1 Animals and housing conditions 
Male Wistar rats (Elevage Janvier, Le Genest-St-Isle, France) were used in all experiments. 
Their mean body weight was 250g at the start of the experiments. The rats were adapted to the 
housing conditions and to handling for 10 days before the experiments started. The animals 
had ad libitum access to tap water and to standard laboratory rodent chow (#3430, 18.5% 
protein; Provimi Kliba, Gossau, Switzerland) except during periods when the animals 
received specific test diets or during food deprivation as described below. All rats were 
individually housed in hanging, stainless steel wire cages (50 x 25 x 18 cm) under controlled 
conditions of illumination (12:12 h light – dark cycle), humidity and temperature (21  1C). 
In some experiments isocaloric custom-made diets (Provimi Kliba AG; Kaiseraugst, 
Switzerland) were used which differed in their protein (18%, 8%, 1%) but not fat content. 
Caloric density (15.1 -15.4 MJ/kg) was adjusted by variable contents of carbohydrates 
(mainly starch). With marginal differences the 18% protein diet had a nutrient composition 
that corresponded to the standard chow. The Veterinary Office of the Kanton Zurich, 
Switzerland, approved all animal procedures and experiments. 
 
2.2 Effect of diet-derived protein on amylin-induced hypophagia and c-Fos 
expression in the AP 
In order to adapt the animals to the respective test diets, the 1%, 8%, or 18% protein diets 
were offered on 2 single days during a 7-10 day habituation period. Before the feeding trials 
that were conducted in intervals of 5 days, the animals received regular chow for 3 days, 
chow in combination with the respective test diet for one day and only the test diet for another 
day. At dark onset, amylin (5µg/kg s.c.; Bachem, Bubendorf, Switzerland) or saline (controls) 
were injected; for the feeding tests, treatments were conducted in a crossover design for each 
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diet in weight-matched groups. Cumulative food intake was measured 30 min, one hour and 
two hours after injection with a precision of 0.1g and correction for spillage. The animals 
were kept on the diet until 24h after the injection and then switched back to chow. The 
amylin-induced c-Fos expression was investigated in separate groups of rats fed 1% vs. 18% 
protein diet. The adaptation of the animals and the treatments were the same as for the feeding 
trials. 
 
 
2.3 Effect of amino acids on amylin-induced c-Fos expression in the AP 
To test the effect of circulating amino acids on the amylin-induced c-Fos expression in the AP 
the amino acid solution Aminoven (Fresenius Kabi Schweiz AG, Oberdorf, Switzerland) was 
used. Aminoven contains 16 different amino acids at a concentration of 15% and is used for 
medical purposes in parenteral nutrition. Four weight-matched groups of rats including a 
saline control group (n=5), an amylin-treated group (n=7), an Aminoven control group (n=8) 
and a group that was treated with Aminoven and amylin (n=7) were used.  
The animals were food-deprived for 24 h and injected with Aminoven (1g/kg i.p.) or saline 20 
min before dark onset. At dark onset, amylin (5 μg/kg s.c.) or saline were injected. Two hours 
after these treatments, the animals were deeply anaesthetized and transcardially perfused with 
ice-cold phosphate buffer solution (PB 0.1 M, pH 7.2) followed by 4% paraformaldehyde 
solution (4% PB 0.1 M) for fixation. Blood was sampled and the glucose concentration was 
measured as described below. The immunohistological detection of c-Fos is described in 
section 2.5. 
 
2.4 Measurements of blood glucose, amino acids and amylin levels 
To measure the effects of the different protein diets on blood glucose and amino acid levels, 
blood samples were taken at dark onset from the lingual vein under isoflurane aneasthesia. 
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The experimental conditions were the same as in the respective feeding trials and c-Fos 
studies. Immediately after blood sampling, the concentration of glucose was measured using a 
glucose-oxidase based glucometer (Glucometer Elite; Bayer, Zürich). 
The blood was then transferred into serum tubes (Microvette 500 Z, Sarstedt, Germany) and 
centrifuged at 2800 rpm for 10 min. A protease inhibitor mixture (P 2714, Sigma - Aldrich) 
was immediately added after blood sampling (10µl of the inhibitor / 1ml blood). The serum 
was then removed and frozen at -20 °C. The Functional Genomics Centre at the University of 
Zurich performed the measurement of amino acid concentrations. 80µl of each serum sample 
were used and 80µl of a 10% sulfasalicyclic acid solution was added for precipitation. 20µl of 
the supernatant was taken and 60µl borate buffer were added to the vial and reconstituted with 
20µl MassTrak Amino Acid Analysis Solution derivatization reagent. 1µl of this vial was 
injected into the Waters Acquity Ultra Performance Liquid Chromatography (UPLC) machine 
equipped with an UV detector (Waters Corporation, Milford, MA, USA) and the samples 
were analyzed. Analyses were carried out according to the manufacturer's instructions. 
 
2.5 Immunohistological studies  
c-Fos single staining 
Single staining c-Fos studies were conducted to investigate the effects of fasting on GLP-1 
and AngII-induced AP activation. Animals were food deprived for 24h before receiving GLP-
1 or AngII at dark onset (100µg/kg or i.p. or 50µg/kg s.c., respectively; both from Bachem, 
Bubendorf, Switzerland). Similar to our previous studies [9], a non-fluorescent approach was 
used for the detection of c-Fos.   
Sections were incubated with a polyclonal rabbit anti-c-Fos antibody (Ab-5, Calbiochem, 
Darmstadt, Germany) in 0.3% PBST (1:5000). After washing in 0.1% PBST (5 x 10 min), the 
brain sections were incubated with the secondary antibody (1:400 biotinylated goat anti-rabbit 
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antibody; Vector Laboratories, Burlingame, California USA) for 90 minutes at room 
temperature. For the diaminobenzidine staining a Vectastain Elite ABC Kit (Vector 
Laboratories, Burlingame, California USA) was used. The staining procedure was identical to 
the methods described in our previous studies [9]. For c-Fos studies conducted to test the 
effects of the diet’s protein content and amino acid treatment on the amylin-induced AP 
activation the same method was used.  
c-Fos stainings were evaluated using a microscope equipped with a digital camera system 
(Axioskop; Carl Zeiss, Feldbach, Switzerland). The experimenter was blinded to the 
experimental groups. c-Fos positive cells were counted in three sections per animal at the mid 
rostro-caudal level of the AP (approximately at bregma -14.04; [23]). The cell counts were 
averaged for each animal. In order to correct for interassay variability appropriate control 
groups were included in all experiments. Group means  SEM was calculated from the 
averaged cell counts of each animal for each treatment group (n = number of animals). 
c-Fos/CTR double staining 
The co-localisation of c-Fos and CTR expression was investigated in 24h fasted rats that 
received the following injections at dark the onset: amylin (5µg/kg s.c), GLP-1 (100µg/kg 
i.p), exendin-4 (2µg/kg i.p.; Bachem, Bubendorf, Switzerland), LiCl (76mg/kg i.p.; Aldrich, 
Buchs SG, Switzerland), AngII (50µg/kg s.c.) or saline as control. Two hours after injections, 
the animals were deeply anaesthetized with pentobarbital sodium (100 mg/kg i.p.) and 
perfused as described above. The brains were removed and postfixed for additional 2h in a 
4% paraformaldehyde solution at 4 °C. After incubation for 48h in 20 % sucrose in PB for 
cryoprotection, the brains snap frozen with CO2.  
Coronal sections (20 µm) of the medulla oblongata at the level of the AP (bregma -14.28mm 
to -13.68mm; [23]) were cut in a cryostat (Leica CM 3050 S, Nussloch, Germany), thaw-
mounted on adhesive glass slides (Super Frost Plus; Menzel Braunschweig, Germany) and 
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stored at -20°C. After 1h air drying, the sections were rehydrated in phosphate buffered saline 
(PBS pH 7.4) for 10min. The slides were incubated with normal donkey serum (1.5% in PBS 
containing 0.3% Triton X100; PBST) for 2h. After 30min of washing, two primary antibodies 
were co-applied in 0.3% PBST for 48h at 4°C: rabbit anti-CTR (1:1000; kindly provided by 
P. Wookey, University of Melbourne, Australia [24]) and goat anti-c-Fos (1:500; sc-52-G, 
Santa Cruz). After washing for 50 minutes, slices were incubated with two secondary 
antibodies: donkey anti-rabbit Alexa-555 (1:100) and donkey anti-goat Alexa-488 (1:200) for 
two hours at room temperature (both from Invitrogen, Basel, Switzerland). The sections were 
rinsed for 30min in 0.1% PBST 0.1% and PBS and then covered with citifluor (Citifluor Ltd., 
London, UK). 
In similar immunohistochemical double staining experiments the co-localization of amylin-
induced formation of the second messenger cyclic guanosine monophosphate (cGMP) and 
CTR was investigated (see supplementary material).   
 
2.7 Statistical Analysis 
All results are presented as mean values  SEM. Statistical comparisons across more than 2 
experimental groups were conducted by one way ANOVA or one way ANOVA on ranks 
(Kruskal-Wallis test) for data that were not normally distributed, followed by the Student-
Newman-Keuls or Dunn’s multiple comparison post hoc test, respectively. In the 
immunohistological studies, the mean value of the cell counts/section of an individual animal 
was used for statistical analyses. Differences in food intake were analyzed using a paired 
Student’s t-test to compare the differences between amylin-treated and their control groups at 
each time point. In all cases p < 0.05 was considered significant. 
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3. Results 
3.1 Modulation of hormonal responsiveness by nutrient stimuli 
 
Baseline intake of the isocaloric diets that differed in protein content was measured over 24h. 
While rats showed similar baseline intake of the 1% and 18% protein diet, the animals ate 
slightly but significantly less of the 8% protein diet (figure 1A). The protein content of the 
diets affected the level of total blood amino acids measured 2h after presentation of the diet. 
Rats receiving the 18% protein diet showed blood amino acid levels that were similar to the 
level observed in rats receiving standard chow. Intake of the 1% and 8% protein diet resulted 
in significantly lower concentration of circulating amino acids (figure 1B). There were no 
differences in the blood glucose levels between three groups (figure 1C). 
Amylin significantly reduced food intake across all groups, i.e. in rats fed the 1%, the 8% or 
the 18% diet. The amylin-induced reduction in food intake was significant after 30 min and 
60 min under all three feeding conditions (figure 2ABC). After 120 min, amylin only reduced 
intake in rats fed the 1% protein diet, but not the 8% or 18% protein diets. When compared to 
the pertinent control groups, amylin caused a stronger relative suppression of 30 and 60 min 
food intake in rats fed the 1% protein diet than in animals receiving the 8% or 18% protein 
diets (figure 2D).  
 
To investigate the influence of the diet-derived protein on the amylin-induced AP activation, 
amylin-induced c-Fos expression was compared in rats fed the 1% or 18% protein diet. There 
was no difference in c-Fos expression between rats fed 18% fed and 1% in the saline-treated 
controls. The amylin-induced c-Fos response in the AP of animals that were fed the 18% diet 
was significantly lower than in animals fed the 1% diet (figure 3). 
The amylin-induced AP activation was also attenuated by intraperitoneal administration of 
amino acids (Aminoven) in 24h fasted rats. Aminoven injection alone did not alter c-Fos 
expression relative to saline treated controls because both groups showed only little c-Fos 
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expression. Although amylin induced a significant c-Fos response in the AP of the 
Aminoven/amylin treated animals, the number of c-Fos expressing cells in the AP was 
significantly lower than in the saline/amylin treated group (figure 4). Notably, the stronger AP 
activation in the latter food-deprived group relative to the ad libitum fed 18% protein diet 
group shown in figure 3 is due to the well-described effect of fasting on amylin-induced c-Fos 
expression [9].     
 
Proceeding from the observation that fasting increases amylin-induced AP activation, we 
investigated whether the responsiveness of AP neurons to GLP-1 or AngII is also stronger 
after 24h fasting. While GLP-1 failed to induce a c-Fos response under ad libitum conditions, 
it induced a significant AP activation in 24h fasted rats (figure 5A). The AngII-induced c-Fos 
responses were weak. AngII elicited a significant AP activation in chow fed animals but not 
in fasted rats, although the mean number of c-Fos positive neurons was similar and not 
significantly different across the two feeding conditions (figure 5B).  
 
3.2 Immuohistochemical phenotyping studies (c-Fos/CTR double staining)  
Amylin treatment elicited a pronounced c-Fos response in the AP while under control 
conditions only few AP neurons were c-Fos positive (Figure 6A-C). In line with the 
assumption that CTR-expressing AP neurons are targeted by amylin, the majority of amylin-
activated cells were CTR positive; in the amylin-treated group 68% of all c-Fos positive 
neurons showed CTR immunoreactivity while no c-Fos/CTR immunoreactive cells were 
detected in the saline treated control group (Figure 6C). As previously described [7] the CTR 
was mainly localized in the cell membranes. A representative immunostaining demonstrating 
the co-localization between amylin-induced c-Fos expression and CTR is shown in figure 6A 
(see figure 6B for higher magnification).  
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GLP-1R stimulation with exendin-4 or GLP-1 significantly increased c-Fos expression in the 
AP (Figure 6D-F and 6J, respectively). Interestingly, both exendin-4 and GLP-1 activated AP 
neurons that did not express the CTR. Only 2-3% of all cells expressing c-Fos after exendin-4 
(Figure 6F) or GLP-1 treatment (Figure 6J) were CTR positive indicating that GLP-1R 
stimulation activates a population of AP neurons that appears to be largely distinct from the 
direct target cells for amylin.  
LiCl induced a strong c-Fos response in the AP. Similar to exendin-4 and GLP-1, LiCl 
predominantly activated CTR negative AP neurons because only 3% of the c-Fos positive AP 
neurons expressed the CTR after LiCl treatment (Figure 6K). AngII induced a moderate but 
significant c-Fos response in the AP. As shown in figure 6G-I hardly any of the c-Fos 
expressing cells were CTR-positive (1%) after treatment with AngII.  
 
4. Discussion 
4.1 Modulation of hormonal responsiveness by nutrient stimuli 
As suggested by our previous studies [9] diet-derived protein seems to attenuate amylin-
sensitivity. These previous studies however did not account for possible effects that might be 
related to differences in caloric intake. Furthermore the previous studies were conducted 
under artificial feeding conditions because the diets only contained single nutrients. We now 
show that amylin`s hypophagic action was much stronger in rats fed the 1% protein diet 
compared to the 8% and 18% diet. To test whether the attenuation of amylin’s hypophagic 
action is paralleled by a reduced amylin-mediated AP activation, the effects of amylin on c-
Fos expression were compared in rats fed the 1% vs. the 18% protein diet. In line with the 
observations of the behavioral experiments, amylin induced a lower c-Fos response in animals 
receiving the 18% protein diet. The excitatory action of amylin on AP neurons is considered 
the primary neuromechanism underlying amylin’s feeding inhibitory effect. It is therefore 
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conceivable that the impact of diet-derived protein on amylin’s hypophagic action is mediated 
by an attenuation of the amylin-responsiveness of AP neurons.  
It might appear unexpected that despite a low c-Fos response, amylin produced a significant 
hypophagic response in rats receiving the 18% protein diet. We observed similar results in 
previous studies [9] conducted with nutritionally equivalent standard chow. Although c-Fos is 
an accepted and useful marker for neuronal activation, the thresholds for amylin-induced c-
Fos expression, amylin-induced neuronal activation and amylin’s effects on feeding do not 
necessarily correspond.  
Interestingly, amylin’s hypophagic effect was similar in rats receiving the 8% and 18% 
protein diets. Therefore, dynamic effects of the protein content on amylin responsiveness 
seem to occur at protein contents of the diet lower than 8% at least when animals are fed ad 
libitum. Unlike the baseline intakes of the different protein diets in our short-term 
experiments, previous studies have demonstrated reduced intake of 2% protein diets under 
chronic feeding conditions [25]. The mechanism behind the reduced low protein intake during 
chronic exposure has not been identified. Taking our current findings into account, it is 
tempting to speculate that an increased responsiveness to endogenous satiation signals might 
have contributed to the reduced low protein intake reported in these studies.      
Notably, under free living or non-laboratory conditions, protein supply is likely to vary, both 
with respect to the frequency of intake (food availability) and in terms of the diet’s protein 
content. For these reasons short-term excursions in protein supply might modulate amylin-
responsiveness under natural feeding conditions. In order to mimic such short-term excursions 
in food availability we investigated amylin-induced c-Fos expression in rats that were food-
deprived for only 1h or 5h before dark onset. Amylin induced only a weak but non-significant 
c-Fos response in ad libitum fed animals (see supplementary material Figure 8A). In contrast, 
amylin-induced c-Fos expression was markedly increased in 5h but not 1h food deprived rats 
relative to ad libitum fed animals. These observations support the assumption that also 
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comparatively moderate restrictions in food availability increase neuronal amylin 
responsiveness.  
According to their protein contents, the diets used in the current study produced significantly 
different levels of blood amino acids (highest value for 18% diet). Hence, a postabsorptive 
effect of circulating amino acids might be relevant for the modulation of amylin-sensitivity 
under the different diet conditions that we tested. The attenuation of amylin-induced c-Fos 
expression in the AP of fasted rats by peripherally injected amino acids seems to confirm this 
hypothesis. The current findings may suggest a direct action of amino acids on amylin-
responsive AP neurons. It also appears plausible that secondary hormonal effects might be 
involved because an increase in circulating blood amino acids represents a stimulus for 
gastrointestinal and pancreatic hormones; however, to study such effects was beyond the 
scope of the present study.  
Based on the current results is appears unlikely that diet-dependent differences in blood 
glucose potentially induced by a different gluconeogenic activity of the diets might have had 
an influence on the effects of amylin. This issue is of particular interest because amylin-
sensitive neurons have been shown to be glucose-responsive [26, 27]. Furthermore, amylin’s 
inhibition of gastric emptying, which also depends on the AP, is overridden by hypoglycemia 
[28]. Such effects most likely do not account for the differences in amylin signaling observed 
in the present study because there were no differences in glucose levels among the diet 
groups. 
 
Interestingly, we also demonstrated an increased AP responsiveness for GLP-1 but not for 
AngII after 24h fasting compared to ad libitum feeding conditions. Based on the proposed 
function of the AP as a possible target site mediating a satiating effect of GLP-1 [17], a 
modulation of responsiveness by the feeding status might have a similar relevance for amylin 
and GLP-1, although the target neurons for these hormones do not seem to be identical. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
15 
Studies directly investigating the influence of the feeding status on GLP-1 mediated effects 
are scare. As demonstrated by in vivo imaging techniques GLP-1 activates the AP in fasted 
mice but this effect has not been compared to ad libitum fed animals [29]. 
 
4.2 Immuohistochemical phenotyping studies (c-Fos/CTR double staining) and 
functional implications 
Consistent with the notion that the CTR represents the core unit of the functional amylin 
receptor [5, 30], Our immunohistological double staining studies clearly indicate that CTR 
expressing AP neurons are major target cells for amylin. The fact that not all amylin-activated 
AP neurons were CTR positive might be explained by an indirect activation of CTR negative 
second-order neurons via AP intrinsic synaptic connections. This assumption is supported by 
our observation of an almost complete co-localization (96%) between amylin-induced cGMP 
formation and CTR expression in the AP (see supplementary material). cGMP is considered 
to be the intracellular second messenger mediating the amylin-induced excitation of AP 
neurons [2]. Therefore, cGMP formation occurs specifically in the first-order target cells for 
amylin but not necessarily in synaptically activated neurons, which is in line with the higher 
degree of co-localization for amylin-induced cGMP/CTR vs. c-Fos/CTR. 
The high overlap between amylin-induced c-Fos expression and CTR immunoreactivity 
contrasts with the absence of activated CTR positive AP neurons after GLP-1R stimulation 
elicited by GLP-1 or exendin-4. This finding suggests the existence of distinct populations of 
primary target cells in the AP for GLP-1 and amylin. It cannot be excluded, however, that 
excitatory amylin signaling indirectly converges on AP neurons that are also activated by 
GLP-1. Exendin-4, LiCl and amylin have been shown to activate catecholaminergic AP 
neurons [4, 31, 32]. Our current findings add to the existing studies by demonstrating a clear 
dissociation between the putative target cells for amylin and neurons that are activated by 
GLP-1 agonists or LiCl. Based on the existing phenotyping studies our current results might 
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imply that CTR positive neurons that are activated by amylin represent a subset of 
catecholaminergic AP neurons. To our knowledge there are currently no published studies 
investigating the neurochemical phenotype of CTR versus non-CTR expressing AP neurons.   
The role of the AP with respect to GLP-1R mediated functions is less understood than AP-
dependent actions of amylin. This particularly applies to the question whether GLP-1 exerts a 
specific satiating effect via the AP or whether GLP-1 signaling in the AP primarily mediates 
aversive sensations such as emesis or nausea. Despite the ability of GLP-1 to produce 
symptoms of visceral illness it has been put forward that different neuronal systems mediate 
GLP-1-induced aversion and specific hypophagic effects. This is supported by the induction 
of anorexia with or without CTA following site-specific central injections of GLP-1. 
Interestingly, fourth ventricular infusion of GLP-1 inhibits feeding at doses that do not cause 
a CTA suggesting a possible involvement of hindbrain GLP-1R in the specific control of food 
intake [20]. Notably, our demonstration that GLP-1R activation does not activate CTR 
positive AP neurons does not exclude the possibility that GLP-1 or exendin-4 stimulate AP 
neurons that are specifically involved in the control of feeding behavior. If so, however, these 
cells are most likely distinct from AP neurons that are directly targeted by amylin but they 
might overlap with a neuronal population of AP neurons that could be synaptically activated 
by amylin signaling.  
Recent studies seem to imply that the experimental conditions add substantial complexity to 
the investigation of possible AP-dependent effects of GLP-1 on feeding behavior. While after 
hepatic portal vein infusion the hypophagic effect of peripherally applied GLP-1 is blunted by 
an AP lesion [17], the effect of intraperitoneally administered exendin-4 is not blocked in AP 
lesioned rats; of note, native GLP-1 was not tested in the latter series of experiments [33]. 
Whether the AP-dependent feeding suppressive effect of GLP-1 was related to an aversive 
action in these studies has not been elucidated. In contrast to amylin, GLP-1 and exendin-4 
are known to induce emesis and nausea in humans [34, 35] and to induce aversive effects in 
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rodents that are reflected by the ability of these peptides to trigger a conditioned taste aversion 
(CTA) [20]. Based on our current findings the differential aversive properties of amylin vs. 
GLP-1/exendin-4 might be attributed to the activation of different subsets of AP neurons.  
The role of the AP in mediating aversive responses is well characterized. The development of 
a LiCl-induced CTA can be prevented by AP lesion [36] or cooling [37] indicating the 
importance of the AP for the processing of aversive stimuli. Our observation that LiCl-
induced neuronal activation does not occur in the target cells for amylin strongly supports the 
idea that the amylin responsive population of AP neurons is not implicated in the perception 
or processing of stimuli producing malaise, which is in line with the lack of such responses 
after amylin treatment. While there seem to be largely discrete subsets of AP neurons 
responding to amylin on one hand and to GLP-1/exendin-4 or LiCl on the other hand, we 
didn’t aim to dissociate the neuronal populations responding to GLP-1R stimulation and LiCl. 
As suggested by previous studies, these populations of neurons might overlap because the 
LiCl-induced c-Fos expression in the AP is blocked by central GLP-1R antagonism [21]. 
Hence, the LiCl-dependent activation of the AP and LiCl-induced CTA appears to be at least 
partly mediated by brain-intrinsic GLP-1, which has been confirmed in analogous behavioral 
studies [38]. 
We have used AngII as a further functional stimulus to dissociate amylin-sensitive cells from 
AP neurons that are involved in the cardiovascular control. The role of the AP as a central 
target site mediating cardiovascular effects of AngII is well known and numerous studies 
demonstrated the relevance of AP-dependent AngII effects on heart rate, blood pressure and 
baroreceptor reflex control in different species [39, 40]. The absence of AngII-induced c-Fos 
expression in CTR positive AP neurons underlines the segregation of amylin-sensitive 
neurons from the neuronal system implicated in cardiovascular control. This finding therefore 
contributes to the validation of our approach to use the CTR as a marker for amylin’s target 
cells in the AP.  
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In conclusion our studies provide evidence that CTR expressing AP neurons represent the 
target cells for amylin in the AP and that these neurons are not activated by GLP-1R receptor 
activation, the aversive stimulus LiCl or AngII. Protein seems to modulate amylin sensitivity 
as reflected by an attenuation of amylin-induced AP activation and hypophagia. Amino acids 
appear to contribute to the attenuation of neuronal amylin responsiveness. These findings 
extend the concept that amylin signaling and amylin’s ability to decrease food intake is 
influenced by diet-derived protein. A diet-dependent modulation of neuronal responsiveness 
in the AP also exists for GLP-1. Whether this effect is protein-dependent remains to be 
demonstrated. The attenuation of amylin and GLP-1 sensitivity by diet-derived nutrients 
might have therapeutic implications, because amylin and GLP-1 receptor agonists are in the 
focus of clinical trials identifying possible anti-obesity and anti-diabetic treatments. 
Importantly, therapeutic approaches combining amylin and GLP-1 analogs yielded promising 
outcome in primate studies [41]. Based on our current findings the feeding status and 
particularly the intake of protein might have a substantial impact on the effectiveness of such 
treatments.  
 
 
Supplementary material 
As reported in our previous studies, amylin induced a strong c-Fos expression in the AP in 
24h fasted rats [9]. To evaluate the effect of shorter periods of food deprivation on amylin 
sensitivity of AP neurons, we investigated amylin-induced c-Fos expression in rats after 5h 
and 1h food deprivation. Amylin induced only a weak but non-significant c-Fos response in 
ad libitum fed animals (supplementary figure 1). In contrast, amylin markedly increased c-Fos 
expression in 5h food deprived rats. The number of activated AP neurons under these 
conditions was not only significantly higher than in the controls but differed also significantly 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
19 
from the mean c-Fos response in chow-fed/amylin-treated rats. Interestingly, 1h food 
deprivation was not sufficient to increase amylin the amylin responsiveness of the AP relative 
to ad libitum feeding conditions. Although the amylin-mediated c-Fos response was 
significant in 1h food deprived rats, it was almost identical and not significantly different 
from the AP activation observed in the ad libitum fed animals of this experiment.  
 
As an independent immunohistological approach to confirm that CTR expressing AP neurons 
are targeted by amylin we conducted a CTR/cGMP double staining after amylin treatment. 
The antibody [42] and the protocol to detect cGMP formation were similar as published 
before [2]. Briefly, ad libitum fed animals were pre-treated with the phosphodiesterase 
inhibitor 3-isobutyl-1-methyl-xanthin (IBMX, 1mg ip, Fluka, Buchs SG, Schweiz) 15 min 
before amylin or saline injection. For this study a higher dose of amylin (20µg/kg s.c.) has 
been used because cGMP is difficult to be detected at lower amylin doses probably due to the 
enzymatic degradation resulting from remaining phosphodiesterase activity. The 
immunohistochemical CTR staining was conducted after the cGMP staining according to the 
procedures described in the material and methods. A secondary donkey anti-rabbit, Cy3-
conjugated antibody was used in a dilution of 1:225 (Milan Analytica, La Roche, Schweiz).   
In line with our published work [2], cGMP positive neurons were absent or very few in 
control animals (n=3, data not shown). Supplementary figure 2 shows a detailed analysis of 
the cGMP/CTR co-localization in one of three amylin-treated rats. With only few exceptions 
almost all cGMP positive AP neurons (96%) expressed the CTR. A similar outcome was 
obtained for the two other amylin-treated rats (not shown).  
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Figure legends 
 
Figure 1 Baseline 24h food intake (A) and blood levels of amino acids (B) and glucose (C) 
measured in animals receiving 1%, 8% or 18% protein diet; dotted line represents the average 
amino acid concentration of animals that received standard chow. Data are expressed as 
means ± SEM. Different letters indicate significantly differences (A: n=12; B and C: n=4-6; p 
< 0.05; one way ANOVA, Student-Newman-Keuls post hoc test). 
Figure 2 Effect of amylin (5µg/kg s.c.) on food intake in rats receiving different test diets 
containing 1%, 8% or 18% protein (A-C). Bars represent group means ± SEM. (n = 12: 1% 
and 18%; n = 10: 8 %) *p<0.05, and ***p<0.001 significantly different from respective 
control (saline) group at individual time points (paired Student t test). D: Food intake of 
amylin treated rats relative to their respective saline treated controls (=100%). Bars with 
different letters are significantly different (p < 0.05; one way ANOVA on ranks, Dunn’ 
multiple comparison test). 
Figure 3 Quantification of the number of c-Fos-IR nuclei in the AP of of rats treated with 
amylin (5µg/kg s.c.) or saline; all rats were fed ad libitum and received 1% or 18% protein 
diet, respectively. Data are expressed as means ± SEM (n=7). Bars with different letters are 
significantly different (p < 0.05; one way ANOVA, Student-Newman-Keuls post hoc test). 
Figure 4 Effect of Aminoven pre-treatment on the amylin-induced c-Fos expression in 
the AP of rats; all rats were fasted for 24h fasted in this experiment. Top: representative 
immunohistochemical c-Fos stainings. Aminoven (1g/kg i.p.), amylin (5μg/kg s.c.); 
aminoven/saline: n=8; aminoven/amylin: n=7, saline/saline: n=5, saline/amylin: n=7; 
Scale bar 50μm. Bottom: quantification of c-Fos positive cells; data are expressed as 
means ± SEM. Significant differences are indicated by different letters (p < 0.05; one way 
ANOVA, Student-Newman-Keuls post hoc test).  
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Figure 5 Quantification of the number of c-Fos-IR nuclei in the AP of ad libitum fed rats 
vs fasted rats after GLP-1 (A, 100μg/kg i.p.) or AngII (B, 50μg/kg s.c.). Data are 
expressed as means ± SEM (n=5). Bars with different letters are significantly different (p 
< 0.05; one way ANOVA, Student-Newman-Keuls post hoc test). 
Figure 6  Representative immunostainings and quantification of c-Fos expressing and c-
Fos/CTR double positive neurons the AP region of rats fasted for 24h. Treatments: (A-C) 
amylin (5μg/kg s.c.),  (D-F) exendin-4 (2μg/kg i.p.), (G-I) AngII (50μg/kg s.c.); (J) GLP-1 
(100μg/kg i.p.), (K) LiCl (76mg/kg i.p.), saline as control for all treatments. White 
squares: area of higher magnifications shown in (B, E, H). Arrow heads: single labeled 
neurons (green: c-Fos; red: CTR), arrows: c-Fos/CTR double positive neurons. Scale bar 
100μm. Data are expressed as means ± SEM (n=5). Bars with different letters are 
significantly different (p < 0.05; one way ANOVA, Student-Newman-Keuls post hoc test). 
 
 
Figure legends of supplementary material: 
Supplementary figure 1 Quantification of the number of c-Fos-IR nuclei in the AP of ad 
libitum fed rats and fasted rats after 5 hrs (A) and 1hr (B) of food deprivation. Rats were 
injected either with amylin (5μg/kg s.c.) or saline. Data are expressed as means ± SEM 
(n=5). Bars with different letters are significantly different (p < 0.05; one way ANOVA, 
Student-Newman-Keuls post hoc test). 
Supplementary figure 2 Representative immunostainings and quantification of 
cGMP/CTR double positive neurons the AP after amylin treatment (5μg/kg s.c.). (A,B) 
Co-localization of cGMP and CTR (arrow heads); scale bar 50μm. (C) Numbers of cGMP 
and cGMP/CTR positive cells in AP sclices. (D) Percentages of cGMP positive AP neurons 
that were positive or negative for CTR after amylin treatment. 
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Figure 6  
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Highlights 
 
 Amylin-induced hypophagia and activation of the area postrema are attenuated 
by diet-derived protein under isocaloric feeding conditions 
 Similar to amylin, glucagon-like peptide 1 (GLP-1) dependent area postrema 
activation is stronger in food deprived versus ad libitum fed rats 
 Amylin-activated area postrema neurons are phenotypically different from cells 
that are activated by GLP-1 or the aversive stimulus LiCl 
 The receptive function of area postrema neurons to amylin/GLP-1 and the 
interaction with nutritional stimuli is relevant for therapeutic approaches against 
obesity   
